Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Comment by panimjon Feb 25, 2018 11:38am

69 Views

Post# 27616947

RE:RE:RE:jmc777

You are absolutely correct maybe “ Jesus “ is here to save us all lol wasting his time on a stock he thinks is a scam. Never made any sense why some here would waste so much of their time
a board bashing a stock they say they will never own.
ONLY THING EVERYONE HAS TO ASK THEMSELVES IS WOULD YOU WASTE
YOUR TIME ON A BOARD BASHING A STOCK YOUR NOT INTERESTED IN

Bullboard Posts

Sirios Resource discovers visible gold in Quebec